BOT

16.9%

38.0¢ botanix pharmaceuticals ltd

Ann: Results of Meeting, page-13

First 13 Last

Share
Profile

Follow
rusty388

1,990 Posts.

758

28/10/19

23:47

Post #: 41110249
Share

Originally posted by Pictorella: ↑

I did attend the meeting. Apart from Vince there were Michael Thurn, Bill Bosch, Stewart Washer and Rob Towner present. Apart from one answer all the talking was done by Vince and Michael. There were 50+ people who attended.

In relation to Matt Callahan Vince was non committal as to when he would return.

There will be cap raise. Vince was open about this but said the timing and details had not been decided.

The posted meeting presentation basically details what was said at the meeting in relation to what to expect from the company in the near term. Vince is a good salesman and has a wealth of experience, prior knowledge and the ability to say a lot without actually saying anything that shouldn't be said.Hence he is the boss man.
I was impressed with Michael Thurn who to me certainly knew his stuff and generated a feeling of confidence in the Rosacea and anti microbial research. He repeated several times the safety shown by their trials will ensure FDA approval.

In answer to a question relating to psoriasis Vince answered while the company has the results it will proceed with other areas of research at this stage.

Vince did acknowledge the need for the company to make an effort to write reports in easier to understand language.

Kawartha gave a good account of his views of the meeting on another thread. I basically agree with him.I do feel juztech may be somewhat harsh in saying most of the audience clammed up when it came to question time. From my point of view it was obvious that the company has a viewpoint and that will be it. So rather than be focused on some witch hunt it seems the best step is to ensure the mistakes are not repeated and move forward. I couldn't help but feel the company knew more than they were letting on.

Vince did say the company was not single minded or focused on one course of action. There is a wealth of talent in the company that will allow it to research, develop, joint venture, or commercialize products themselves. The options are many and varied.

After the meeting I did manage to speak with Vince. I have no doubt he fully expected the US results should have been the same as the Aussie ones and the company was shocked at what actually happened. One of the things I asked was if the deal with Purisys eliminated the problems of multiple suppliers and associated problems why not repeat the US phase 2 trials even if on a reduced scale as this would re-instore faith in the company which would be reflected in the share price. He answered that this had been considered but they were moving on.

We then briefly spoke of the antimicrobial results.

It was a long day but I am certainly glad I attended as it was most informative both to listen to and also to see some of the faces who attended. My feelings of doom and gloom stemming from the phase 2 reports have abated. It may take a little longer than expected but I am sure success will be achieved.

I hope I have been of some help to you Rusty.

Expand

Brilliant, thank you very much.

I appreciate it.

BOT Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

There are more pages in this discussion • 28 more messages in this thread...

First 13 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 38.0¢		Change 0.055(16.9%)		Mkt cap ! $687.8M

Open	High	Low	Value	Volume
33.0¢	38.0¢	33.0¢	$7.103M	19.63M

Buyers (Bids)

No.	Vol.	Price($)
5	134000	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
38.0¢	650314	19

View Market Depth

No.	Vol.	Price($)
4	132500	0.375
3	7752	0.370
2	24000	0.365
1	4166	0.360
3	59669	0.355

Price($)	Vol.	No.
0.380	502144	15
0.385	164500	4
0.390	276986	11
0.395	750000	5
0.400	660032	20

Last trade - 16.10pm 12/07/2024 (20 minute delay)

BOT (ASX) Chart

Ann: Results of Meeting, page-13

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Nimy to raise $1.21M to explore 'newsy' WA targets

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Results of Meeting, page-13

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Immutep reports strong response rate from immunotherapies treating carcinomas

Nimy to raise $1.21M to explore 'newsy' WA targets

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News